Grantham, Mayo, Van Otterloo & Co (GMO)’s ASML ASML Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$302M	Sell	151,987 -2,583	-2%	-$4.11M	0.68%	33
2026 Q1	$204M	Buy	154,570 +24,077	+18%	+$33M	0.52%	33
2025 Q4	$140M	Buy	130,493 +105,867	+430%	+$110M	0.36%	36
2025 Q3	$23.8M	Buy	24,626 +18,677	+314%	+$14.7M	0.07%	151
2025 Q2	$4.77M	Buy	5,949 +2,118	+55%	+$1.52M	0.01%	303
2025 Q1	$2.54M	Buy	3,831 +2,893	+308%	+$2.1M	0.01%	365
2024 Q4	$650K	Buy	938 +181	+24%	+$130K	﹤0.01%	488
2024 Q3	$631K	Buy	+757	New	+$677K	﹤0.01%	477

Other funds holding ASML

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ASML Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its ASML (ASML) stake by 1.7% in Q2 2026, selling an estimated $4.11M and leaving 151,987 shares worth $302M. The position accounts for 0.68% of the portfolio, ranked #33.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ASML in Q3 2024 and has held it in 8 quarters since. 2,504 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

Grantham, Mayo, Van Otterloo & Co (GMO) held 151,987 shares of ASML worth $302M as of Q2 2026.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 2,583 ASML shares in Q2 2026, an estimated $4.11M.
ASML made up 0.68% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #33 holding.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ASML in Q3 2024 and has held it in 8 quarters since.
2,504 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.